NAIROBI, 27 February 2021 – Kenya will receive its first batch of COVID-19 vaccine doses next week, according to a statement by cabinet.
Authorities in Nairobi have not said which of the vaccines Kenya will be receiving.
Earlier this month, Kenya’s health ministry said public health officials in the east African nation had sequenced the AstraZeneca vaccine and approved it for use in the country.
The inoculation program in Kenya will prioritize frontline health professionals, the elderly, security officers, teachers and persons with underlying health conditions, according to the ministry of health.
Kenya has confirmed 105,057 cases of COVID-19, with at least 1,853 deaths and 86,521 full recoveries from the virus as of Saturday, 27 February 2021.
With the approval for emergency use expected Saturday of the Johnson & Johnson vaccine, Kenya has a bigger pool of effective vaccines to draw from, including Pfizer/BioNTech, Moderna, AstraZeneca, Sinopharm, Sputnik V, among others.